Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions

被引：0
|
作者：
Calip, Gregory S. [1 ,2 ]
Patel, Pritesh R. [1 ]
Adimadhyam, Sruthi [1 ]
Xing, Shan [1 ]
Wu, Zhaoju [1 ]
Sweiss, Karen [1 ]
Schumock, Glen T. [1 ]
Lee, Todd A. [1 ]
Chiu, Brian C. H. [3 ]
机构：
[1] Univ Illinois, Chicago, IL USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Univ Chicago, Chicago, IL 60637 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
34
引用
收藏
页码：18 / 19
页数：2
相关论文
共 50 条
  • [1] Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions
    Calip, Gregory S.
    Patel, Pritesh R.
    Adimadhyam, Sruthi
    Xing, Shan
    Wu, Zhaoju
    Sweiss, Karen
    Schumock, Glen T.
    Lee, Todd A.
    Chiu, Brian C. -H.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (05) : 1062 - 1071
  • [2] Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors
    Calip, Gregory S.
    Lee, Wan-Ju
    Lee, Todd A.
    Schumock, Glen T.
    Chiu, Brian C-H.
    [J]. BLOOD, 2015, 126 (23)
  • [3] The development of psoriasis in patients treated with tumor necrosis factor-alpha inhibitors for rheumatologic conditions: A case series
    Dutz, J.
    de Gannes, G. C.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (06) : 1424 - 1424
  • [4] Polymorphic structure of the tumor necrosis factor and lymphotoxin alpha loci in non-Hodgkin's lymphoma patients
    Warzocha, K
    Bienvenu, J
    Charlot, C
    Renard, N
    Ribeiro, P
    Coiffier, B
    Salles, G
    [J]. EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 400 - 400
  • [5] Infections in patients affected by rheumatologic diseases associated to glucocorticoid use or tumor necrosis factor-alpha inhibitors
    Fica, Alberto
    [J]. REVISTA CHILENA DE INFECTOLOGIA, 2014, 31 (02): : 181 - 195
  • [6] Non-Hodgkin's lymphoma presenting as anasarca:: Probably mediated by tumor necrosis factor alpha (TNF-α)
    Jillella, AP
    Day, DS
    Severson, K
    Kallab, AM
    Burgess, R
    [J]. LEUKEMIA & LYMPHOMA, 2000, 38 (3-4) : 419 - 422
  • [7] Tumor Necrosis Factor (TNF) and Lymphotoxin-α (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium
    Skibola, Christine F.
    Bracci, Paige M.
    Nieters, Alexandra
    Brooks-Wilson, Angela
    de Sanjose, Silvia
    Hughes, Ann Maree
    Cerhan, James R.
    Skibola, Danica R.
    Purdue, Mark
    Kane, Eleanor
    Lan, Qing
    Foretova, Lenka
    Schenk, Maryjean
    Spinelli, John J.
    Slager, Susan L.
    De Roos, Anneclaire J.
    Smith, Martyn T.
    Roman, Eve
    Cozen, Wendy
    Boffetta, Paolo
    Kricker, Anne
    Zheng, Tongzhang
    Lightfoot, Tracy
    Cocco, Pierluigi
    Benavente, Yolanda
    Zhang, Yawei
    Hartge, Patricia
    Linet, Martha S.
    Becker, Nikolaus
    Brennan, Paul
    Zhang, Luoping
    Armstrong, Bruce
    Smith, Alex
    Shiao, Renee
    Novak, Anne J.
    Maynadie, Marc
    Chanock, Stephen J.
    Staines, Anthony
    Holford, Theodore R.
    Holly, Elizabeth A.
    Rothman, Nathaniel
    Wang, Sophia S.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (03) : 267 - 276
  • [8] Cutaneous pseudolymphoma induced by tumor necrosis factor-alpha inhibitors
    Yokota, Masaki
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : E217 - E219
  • [9] T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
    Deepak, Parakkal
    Sifuentes, Humberto
    Sherid, Muhammed
    Stobaugh, Derrick
    Sadozai, Yama
    Ehrenpreis, Eli Daniel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (01): : 99 - 105
  • [10] Bradypnea in a child taking tumor necrosis factor-alpha inhibitors
    Sener, Seher
    Basaran, Ozge
    Bilginer, Yelda
    Kiper, Nural
    Ozen, Seza
    [J]. PEDIATRIC PULMONOLOGY, 2022, 57 (09) : 2267 - 2268
12345